Kerry Wentworth, Chief Regulatory Officer at Flexion Therapeutics, appointed to Massachusetts Biotechnology Council Board
Flexion Therapeutics today announced that Kerry Wentworth, Chief Regulatory Officer, has been appointed to the Massachusetts Biotechnology Council Board of Directors.
Format
JPEG
Source
Flexion Therapeutics, Inc.